ABBV Latest Headlines

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

at www.tipranks.com (Fri, 4-Sep 9:40 AM)

Analysts Are Bullish on These Healthcare Stocks: Eledon Pharmaceuticals (ELDN), AbbVie (ABBV)

at www.tipranks.com (Fri, 4-Sep 9:10 AM)

Scotiabank Remains a Buy on AbbVie (ABBV)

at www.tipranks.com (Fri, 4-Sep 7:35 AM)

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Ionis Pharmaceuticals (IONS) and AbbVie (ABBV)

at www.tipranks.com (Fri, 4-Sep 6:50 AM)

AbbVie succeeds in late-stage trial for multiple myeloma drug

at seekingalpha.com (Thu, 3-Sep 10:16 AM)

Stocks with the lowest short interest on Wall Street

at seekingalpha.com (Thu, 3-Sep 10:08 AM)

AbbVie seals $11B acquisition of Apogee Therapeutics

at seekingalpha.com (Thu, 3-Sep 9:24 AM)

AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio

at www.tipranks.com (Thu, 3-Sep 9:16 AM)

AbbVie Expands Long-Term Support with $6 Million Immunology Scholarship, Now Marking a Decade of Impact

Market Chameleon (Tue, 18-Aug 9:44 AM)

JUVDERM Day Returns as Allergan Aesthetics Celebrates 20th Year with Buy-One-Get-One Offer for Alle Members

Market Chameleon (Thu, 30-Jul 8:53 AM)

AbbVie’s TEPKINLY Combination Gains EU Approval, Marking 79% Reduced Disease Progression Risk for Follicular Lymphoma

Market Chameleon (Tue, 7-Jul 8:11 AM)

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Move, Expanding Leadership in Immunology

Market Chameleon (Mon, 22-Jun 7:52 AM)

AbbVie’s Nine-Year CLL Data Signals Durable Treatment Benefits for Patients Using Venetoclax Combinations

Market Chameleon (Fri, 12-Jun 11:34 AM)